2-[4-[3-(4--3-u-2-)]]- Ӣ 2-[4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy]acetic acid ܶ 1.20.1 g/cm3 c(din) 600.855.0 C at 760 mmHg c(din) 127-128?C(lit.) ʽ C22H26O7
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0113389 | 100mg |
1
|
ԃr(ji) |
Q-0113389 | 250mg |
1
|
ԃr(ji) |
Q-0113389 | 500mg |
1
|
ԃr(ji) |
Q-0113389 | 1g |
1
|
ԃr(ji) |
Q-0113389 | 5g |
1
|
ԃr(ji) |

2-[4-[3-(4--3-u-2-)]]-
Ӣ 2-[4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy]acetic acid
ܶ 1.2±0.1 g/cm3
c(din) 600.8±55.0 °C at 760 mmHg
c(din) 127-128ºC(lit.)
ʽ C22H26O7
402.438
Wc(din) 206.5±25.0 °C
|(zh) 402.167847
PSA 102.29000
P(gun)a(chn)Ʒ
2--3--5- CAS:124432-70-8
ɳs|(zh)C(}}) CAS:1243308-37-3
RN486 CAS:1242156-23-5
1H--3- CAS:1239363-47-3
(R)-(-)-4-sˮ CAS:123750-60-7
4--3,5-S CAS:123688-59-5
Prulifloxacin CAS:123447-62-1
27--99--9H- CAS:1229603-71-7
h(hun)ϩïF CAS:12260-67-2
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹã
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
Ӣ heptyl (E)-3-phenylprop-2-enoate ܶ 0.987g/cm3 c(din) 350.1?C at 760mmHg ʽ C16H22O2 246.34500
-
1-(4-ȱ)-5-(2--2-һ)-1H-1,2,3--4- Ӣ methyl 1-(4-chlorophenyl)-5-(2-methoxy-2-oxoethyl)triazole-4-carboxylate ܶ 1.4g/cm3 c(din) 468.1?C at 760mmHg c(din) 124-126?C ʽ C13H12ClN3O4 309.70500 Wc(din) 236.9?C